Becton, Dickinson and Company (BDX) – COVID 19 Testing sales created positive impact on company performance

in , on February 15, 2021

BDX’s expanding innovation pipeline is focused on healthcare’s shifting trends leveraging BD’s core strengths. The company is applying smart devices, robotics & analytics/AI to improve care processes
and lower costs.

Highlights 

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Developments
– M&A Deals

 Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership 

Stock Price Performance

CrispIdea Coverage

No of Pages : 36

Release Information

  • Released
    :

    February 15, 2021

  • Last Updated
    :

    February 23, 2021